Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Effects of Oral and Intravenous Lipid Administration on Leptin Signaling

NCT01520454 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT01520454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01520454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Effects of Oral and Intravenous Lipid Administration on Leptin Signaling
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
December 31, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leptin resistance, obesity